Insider Transactions in Q1 2022 at Ab Cellera Biologics Inc. (ABCL)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 04
2022
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
10,000
+15.15%
|
$80,000
$8.54 P/Share
|
|
Mar 01
2022
|
John S. Montalbano Director |
BUY
Open market or private purchase
|
Direct |
20,000
+30.3%
|
$180,000
$9.05 P/Share
|
|
Feb 28
2022
|
Veronique Lecault Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
230,789
+12.82%
|
$1,846,312
$8.66 P/Share
|
|
Feb 22
2022
|
Carl L. G. Hansen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,125
+16.67%
|
$112,250
$2.7 P/Share
|